Zhitong Finance App News, Tide Pharmaceutical (03880.HK) announced that in order to advance the production capacity strategic layout of the Group's peptide and oligonucleotide CDMO business, the Group has signed an acquisition agreement for an industrial site and real estate located in Qiantang District of Hangzhou. As of the date of this announcement, the relevant acquisition has been completed, and it is intended to be the first phase of the Group's large-scale CDMO production base project (this project).

Zhitongcaijing · 2d ago
Zhitong Finance App News, Tide Pharmaceutical (03880.HK) announced that in order to advance the production capacity strategic layout of the Group's peptide and oligonucleotide CDMO business, the Group has signed an acquisition agreement for an industrial site and real estate located in Qiantang District of Hangzhou. As of the date of this announcement, the relevant acquisition has been completed, and it is intended to be the first phase of the Group's large-scale CDMO production base project (this project).